iqvia glp-1 prescriptions semaglutide tirzepatide q3 2024 prescription trends through June Eli Lilly Stock Will 'Dominate'

Weight loss results with Tirzepatide vary from person to person, as factors like dosage, individual metabolism, diet, and physical activity play an important role

An FDA notice states that "prescribers may still see intermittent localized supply disruptions as the products move through the supply chain." The FDA's entry for tirzepatide on its online shortage list says patients might not be able to fill their prescription at a particular pharmacy right away

Around 1 in 8 adults say they have used a GLP-1 agonist

The World Health Organization (WHO) reports that nearly 2.5 billion adults have higher body weight and 890 million have extreme body weight

Calcitonin is a tumor marker for medullary thyroid carcinoma, so elevated levels theoretically warrant attention

Although you can switch from Zepbound to Ozempic if your healthcare provider recommends it, theres no guarantee that insurance will cover Ozempic